Tradestie Institutional Equity Comparison Engine
KTTA vs ISPC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KTTA Overall Edge
KTTA Captures Institutional Edge (2โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus ISPC at N/M Forward P/E and -1455.3% operating margin (+128.9% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ISPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
KTTA N/M vs ISPC N/M Fwd P/E
Growth & Margin Winner
KTTA
Op Margin 0.0% vs -1455.3% ยท YoY +1498.1% vs +128.9%
Momentum & Technical Winner
KTTA
1Y +0.6% vs -10.0% ยท 52W Pos 11% vs 5%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA
NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap
$17.7M
1M Return
+7.52%
1Y Return
+0.59%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 20.0
Fund 40.0
Flow 50.0
Mom 60.0
ISPC
NASDAQ
iSpecimen Inc. Common Stock
Services-Commercial Physical & Biological Research
$0.46
-13.58% 1D
Market Cap
$3.1M
1M Return
-45.2%
1Y Return
-10.0%
Forward P/E
N/M
Unified AI Score
41.6 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KTTA +0.59%
ISPC -10.0%
Spread: +10.59 pp (KTTA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KTTA Revenue | ISPC Revenue | KTTA Op. Margin | ISPC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | N/A | $10M | N/A | -29.4% | ISPC |
| FY2021 | $0M | $10M | -29925.7% | -53.2% | ISPC |
| FY2022 | $0M | $10M | -2587.3% | -97.9% | ISPC |
| FY2023 | N/A | $10M | N/A | -112.5% | ISPC |
| FY2024 | N/A | $10M | N/A | -137.0% | ISPC |
| FY2025 | N/A | $0M | N/A | -465.4% | ISPC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KTTA | ISPC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $17.7M | $3.1M | Larger Scale | KTTA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +1498.1% | +128.9% | Higher Growth | KTTA |
| Operating Margin (TTM) Profitability | 0.0% | -1455.3% | Higher Margin | KTTA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -88.8% | -303.9% | Higher ROE | KTTA |
| 52-Week Range Position Momentum | 11% ($0โ$2) | 5% ($0โ$7) | Stronger Trend | KTTA |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 185% Vol | -10.07ฮฒ ยท 74% Vol | Lower Realized Risk | ISPC |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 41.6 / 100 (SELL) | Higher Composite | KTTA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KTTA vs ISPC Buy Guide
KTTA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ISPC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KTTA nor ISPC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.